Good news for vegetarians! CSIR survey says those with such dietary preference may have lesser risk of contracting coronavirus

By: |
January 17, 2021 8:37 PM

The survey also found that those with blood group 'O' may be less susceptible to the infection, while people with 'B' and 'AB' blood groups were at a higher risk.

The 2nd dose of COVID-19 vaccination started on February 13 for those beneficiaries who have completed 28 days after receipt of the 1st dose.The 2nd dose of COVID-19 vaccination started on February 13 for those beneficiaries who have completed 28 days after receipt of the 1st dose.

Smokers and vegetarians were found to have lower seropositivity indicating that they may be at a lesser risk of getting infected by coronavirus, according to a pan-India serosurvey conducted by the Council of Scientific and Industrial Research in its nearly 40 institutes. The survey also found that those with blood group ‘O’ may be less susceptible to the infection, while people with ‘B’ and ‘AB’ blood groups were at a higher risk. For its study, the Council of Scientific and Industrial Research (CSIR) took samples of 10,427 adult individuals working in its laboratories or institutions and their family members, based on voluntary participation, to assess the presence of antibodies to SARS-CoV-2. The study which was piloted by CSIR-Institute of Genomics and Integrative Biology (IGIB), Delhi said of the 10,427 individuals, 1,058 (10.14 per cent) had antibodies against SARS-CoV-2.

A follow up on 346 seropositive individuals among the samples after three months revealed ‘stable’ to ‘higher’ antibody levels against SARS-CoV-2, but declining plasma activity for neutralizing the virus, Shantanu Sengupta, senior scientist at IGIB and one of the co-authors of the paper said. A repeat sampling of 35 individuals, at six months, revealed declining antibody levels while the neutralising antibody remained stable compared to three months.

However, both the normal antibody as well as the neutralising antibody were much above the required threshold, he said. “Our finding that smokers are less likely to be seropositive is the first report from the general population and part of growing evidence that despite COVID-19 being a respiratory disease, smoking may be protective,” the study said.

The paper also cites two studies from France and similar reports from Italy, New York and China, which reported lower infection rates among smokers. Along with demographic information, possible risk factors were evaluated through self-filled online forms with data acquired on blood group type, occupation type, habits including smoking and alcohol, diet preferences, medical history and transport type utilised.

The study found that higher seropositivity was found for those using public transport and with occupational responsibilities such as security, housekeeping personnel, non-smokers and non-vegetarians, Sengupta said. “The presence of such antibodies is a reliable marker of infection and recovery. However, some infected people may not develop antibodies,” Anurag Agrawal, IGIB director, and one of the co-authors of the paper said. “Use of private transport, lower-exposure occupations, smoking, vegetarianism and ’A’ or ‘O’ blood groups appeared to be protective, using seropositivity as a surrogate for infection,” the paper added.

Sengupta said this is for the first time that a study has been done in India wherein individuals have been monitored for three months (35 individuals) to six months (346 individuals) for antibodies including those with probable neutralising activity. This is the first such cohort survey, he said. “We conducted both the normal antibody test and neutralising anti-body test to understand the prevalence and duration of antibodies,” he said. The CSIR has some 40 institutes covering the length and the breadth of the country and each specialises in different fields. The IGIB and its sister institute Centre of Cellular and Molecular Biology have been at the forefront in conducting the genome sequencing of coronavirus.

 

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Cumulative Covid vaccine doses administered in India exceed 42.75 cr: Health ministry
2Bharat Biotech terminates MoU with Brazilian partners after graft allegations
3Nine states still have over 10,000 active Covid cases: Govt